Analyses of the ARM-TD and AIM-TD trials indicate that deutetrabenazine performs better than placebo as treatment for tardive dyskinesia.
Four-year results show that motor complications, but not burden of nonmotor symptoms, can predict death in patients with Parkinson’s disease.
New research suggests that baseline gut microbiota may predict the progression of Parkinson’s disease at 2 years.
Pulse pressure was associated with the risk for ischemic stroke in first-ever ischemic stroke patients old than 60 years.
A 150-year-old drug, apomorphine, may reduce off time in patients with Parkinson’s disease.
Non-demented elderly patients experiencing excessive daytime sleepiness may be at increased risk for β-amyloid accumulation.
A newly published guideline shines light on sudden unexpected death in epilepsy and how clinicians can help prevent it.
Women with a history of migraine are at increased risk for developing hypertension.
Serum neurofilament light chain levels show potential in predicting the burden and progression of cerebral small vessel disease.